Zenith DrugsNSE:ZENITHDRUG -0.11%14 FCF Margin % is -20.19% as of Sep. 2025. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 14/100. The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, Zenith Drugs ranks worse than 74.74% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zenith Drugs's Free Cash Flow for the
six
months ended in Sep. 2025 was ₹-158 Mil. Zenith Drugs's Revenue for the
six
months ended in Sep. 2025 was ₹782 Mil. Therefore, Zenith Drugs's FCF Margin % for the quarter that ended in Sep. 2025 was -20.19%.
The historical rank and industry rank for Zenith Drugs's FCF Margin % or its related term are showing as below:
NSE:ZENITHDRUG'
s FCF Margin % Range Over the Past 10 Years
Min: -28.31 Med: -9.03 Max: -0.1
Current: -10.98
During the past 5 years, the highest FCF Margin % of Zenith Drugs was -0.10%. The lowest was -28.31%. And the median was -9.03%.
NSE:ZENITHDRUG's FCF Margin % is ranked worse than 74.74% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs NSE:ZENITHDRUG: -10.98
Zenith Drugs FCF Margin % Related Terms
Zenith Drugs FCF Margin % Historical Data
* Premium members only.
The historical data trend for Zenith Drugs's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ZENITHDRUG vs ZTS, UTHR: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Drugs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenith Drugs FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zenith Drugs's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Zenith Drugs's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenith Drugs (NSE:ZENITHDRUG) has a FCF Margin % of -20.19% as of Sep. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zenith Drugs and its competitors. According to the industry distribution chart, Zenith Drugs ranks #716 out of 958 companies in the Drug Manufacturers industry, placing it in the top 74.7%.
Is Zenith Drugs' FCF Margin % too high?
Zenith Drugs' current FCF Margin % is -20.19%. Based on the distribution chart, Zenith Drugs ranks #716 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zenith Drugs has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zenith Drugs ranks #716 out of 958 companies for FCF Margin %. This places Zenith Drugs in the lower half of its industry. The industry median FCF Margin % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zenith Drugs and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenith Drugs's current FCF Margin % is -20.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current FCF Margin % of -20.19%. The current FCF Margin % is -20.19%. Zenith Drugs' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current FCF Margin % is -20.19% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
14GF Score
Get the complete analysis for NSE:ZENITHDRUG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZENITHDRUG has been successfully added to your 